Oncora Medical

What Oncora Medical does

Oncora Medical (rebranded as Oncora AI in July 2025) is a Philadelphia-based digital health company that builds oncology-specific artificial intelligence software for cancer care delivery, cancer registry operations, and oncology clinical research. The company's product suite comprises three core offerings: Registry AI, which automates cancer registry workflows including case finding, NAACCR-compliant data abstraction, and follow-up monitoring; Clinical AI, an oncology-tuned AI scribe and documentation tool that extracts structured oncology data from pathology, radiology, and clinical notes via FHIR interfaces; and Research AI, which automates patient cohort identification, study design, and statistical analysis for oncology clinical trials. Underlying these products is a proprietary domain-specialized LLM trained on data from hundreds of thousands of cancer patients across leading academic cancer centers, integrated with major EHR and oncology information systems including Epic (via FHIR), MOSAIQ, and ARIA.

Oncora sells primarily through a direct enterprise sales motion targeting large academic cancer centers, integrated delivery networks, and hospital cancer registry programs; named customers include MD Anderson Cancer Center, the Mass General-led Pediatric Proton/Photon Consortium Registry (covering 19 radiation centers), Northwell Health, Scripps Health, and UT Health San Antonio. Revenue is generated via SaaS subscription licensing, with a free pathology report analyzer available to drive enterprise pipeline. A strategic channel partnership with Varian (also a $3M investor in 2019) provides distribution leverage into the radiation oncology installed base. The company was founded in 2015 by Dr. David Lindsay and Chris Ahern, has raised roughly $7M+ in disclosed funding across seed and corporate rounds, and in 2025 expanded leadership with CTO Kevin Yee (ex-Microsoft, Genentech) to support its repositioning as an AI-led clinical data abstraction company.

Name

Oncora Medical

Legal name

Oncora Medical, Inc.

Website

https://oncora.ai

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

11–50 employees

Short description

Oncora Medical (rebranded as Oncora AI in 2025) is a Philadelphia-based digital health company building oncology-specific AI software for cancer registry automation, clinical documentation, and research cohort identification, sold via enterprise SaaS to academic cancer centers and health systems.

Ownership category

akta.pro rank

Product category

Oncology AI Software

NAICS

Software Publishers (513210), Software Publishers (5132), Custom Computer Programming Services (541511)

SIC

Services-Prepackaged Software (7372), Services-Computer Programming, Data Processing, Etc. (7370), Services-Computer Processing & Data Preparation (7374)

akta.pro primary industry

Oncology Pathways & Precision Medicine Decision Support (HLACAGAH)

akta.pro secondary industries

Healthcare Terminology, Ontology & Code Set Management (SNOMED/LOINC/ICD/RxNorm) (HLACAIAF), Clinical Decision Support & Workflow Integration (EHR/oncology systems) (HLAAANAE), Biostatistics, Statistical Computing & Clinical Programming (SAS/R/Pipelines) (HLACAOAO)

Keywords

• Oncology AI software
• Cancer registry automation
• Clinical documentation AI
• Healthcare data analytics
• EHR integration platform

Headquarters

HQ city

Philadelphia

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Enterprise Software Licensing: SaaS-based software platform subscription model providing access to Registry AI, Clinical AI, and Research AI products with enterprise-level features and support.
2. Free Demo Tool: Free demonstration tool for pathology report analysis demonstrating platform capabilities to drive enterprise sales conversions.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels4 records

Core offering

Oncora Medical develops AI-powered oncology software products that automate cancer registry workflows, clinical documentation, and clinical research for healthcare organizations. The platform comprises Registry AI (cancer registry automation with NAACCR coding), Clinical AI (oncology-specific AI scribe), and Research AI (clinical research cohort matching and EDC generation), all built on proprietary large language models and integrated with leading EHR systems (Epic, MOSAIQ, ARIA) via FHIR interfaces.

Product overview

Oncora Medical (reincorporated as Oncora AI in 2025) offers a unified oncology AI platform with three core products: Registry AI for cancer registry automation, Clinical AI for AI-powered documentation and scribing, and Research AI for clinical research acceleration. The platform uses FHIR integration to connect with major EHR systems (Epic, MOSAIQ, ARIA) and applies specialized LLM and ML models for data extraction, predictive analytics, and automated coding. All products share a common data infrastructure with NAACCR compliance and are designed to work both independently and as an integrated suite, with a free demonstration tool available for evaluation.

Differentiator

Problem solved

Functional benefit

Brands

• Registry AI: AI-powered cancer registry automation tool that transforms cancer registry workflows, featuring automated case finding, intelligent abstraction to NAACCR format, and real-time follow-up monitoring.
• Clinical AI
• Research AI
• Oncora Patient Care
• Oncora Analytics

Products and services

• Registry AI AI-powered cancer registry automation tool that transforms cancer registries into strategic assets by automatically extracting data from pathology reports, radiology studies, and clinical documents and translating them into standardized NAACCR coding format with quality control, analytics, and insights. Includes intelligent case finding, AI-enabled abstraction, follow-up monitoring, and analytics and reporting modules.
• Clinical AI AI scribe for oncology that extracts critical oncology-specific data from medical documents through FHIR interfaces, creates intuitive cancer care workflows, and generates customized clinical documentation including orders, prescriptions, progress visit notes, and treatment summaries that meet all clinical requirements.
• Research AI Clinical research AI assistant that transforms clinical data into research-ready cohorts by automatically extracting structured data from FHIR sources including pathology reports, radiology studies, and clinical notes. Provides cohort matching, statistical analysis (including Kaplan-Meier survival curves), custom dashboards, collaboration tools, and next-generation EDC form generation.
• Free Medical Document Analyzer Free web-based demonstration tool that transforms pathology reports, radiology reports, and clinical notes into standardized NAACCR coding format using Oncora's AI. Processes sample patient reports client-side without storing PHI to showcase platform capabilities to prospective enterprise customers.

Quantifiable outcome

• Reduces manual case finding review time by up to 85%
• +3 more outcomes

Named customers6 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration6 records

AI capability8 records

Feature7 records

Partnerships

Six partnerships are on record, tiered core and minor.

• Mass General Cancer Center (Pediatric Proton/Photon Consortium Registry)coreStrategic or Co-development Partner · 22 December 2020Oncora selected to power the PPCR registry with Oncora Analytics software platform. The registry is a consented registry for pediatric cancer patients enabling rapid research into proton therapy impact on children. Dr. Torunn Yock leads the project. Includes 19 radiation centers including MD Anderson, UPenn, Northwestern, Washington University, and University of Florida.
• TmunitycoreStrategic or Co-development Partner · 4 November 2019Strategic collaboration to access Oncora's proprietary real-world data platform to support design of future clinical programs with cell therapy. Partnership aims to accelerate availability of CAR-T therapies for cancer patients by leveraging real-world data.
• Northwell HealthcoreTechnology or Integration · 1 October 2019New York's largest health system partnered with Oncora to use data-powered software for targeted cancer treatment. Oncora's software used by Northwell oncologists to develop personalized treatment plans for cancer patients.
• VariancoreStrategic or Co-development Partner · 1 September 2019Varian invested in Oncora Medical and partnered to accelerate development of software tools for precision medicine in radiation oncology. Partnership combines Varian's radiation oncology systems with Oncora's predictive modeling engine and analytics platform to help doctors design treatments that minimize toxicity risk and maximize chance for cure. Oncora's software was in use at 13 sites at the time of partnership.
• Texas Medical Center (TMCx Accelerator)minorImplementation/ SI/ Consulting Partner · 8 February 2019Oncora Medical was selected for the 16-week TMCx program at the Texas Medical Center Innovation Institute, described as the largest medical complex in the world, for acceleration and validation support.
• MD Anderson Cancer CentercoreStrategic or Co-development Partner · 4 April 2017Precision medicine alliance combining tools for collection and prediction of oncology outcomes to enable precision radiation oncology. Oncora Patient Care developed in conjunction with MD Anderson oncologists. Oncora Analytics in use at MD Anderson for research purposes.

Scale indicators6 records

Recent moves7 records

Expansion highlights6 records

Market position

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/oncoramed
• Facebookfacebook.com/oncoramed
• LinkedInlinkedin.com/company/4834303

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds5 records

Investors6 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Oncora Medical